Join Drs. Mike Wilkes and Mark Ebell as they discuss a new randomized trial of probiotics for UTI: 
<a href="https://pubmed.ncbi.nlm.nih.gov/38084984/" target="_blank" rel="ugc noopener noreferrer">Gupta V, Mastromarino P, Garg R. Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2024;78(5):1154-1161.</a>

Join Drs. Mike Wilkes and Mark Ebell as they discuss a new randomized trial of probiotics for UTI: Gupta V, Mastromarino P, Garg R. Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2024;78(5):1154-1161.

Join Drs. Mike Wilkes and Mark Ebell as they discuss a new randomized trial of probiotics for UTI: 
<a href="https://pubmed.ncbi.nlm.nih.gov/38084984/" rel="noopener noreferrer">Gupta V, Mastromarino P, Garg R.&nbsp;Effectiveness of prophylactic oral and/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2024;78(5):1154-1161.</a>

Episode 6: Probiotics reduce likelihood of frequent UTIs

Join primary care physicians Michael Wilkes MD from UC Davis and Mark Ebell MD, MS from Michigan State University as they discuss a new practice changing study every week. Studies are selected for their ability to change our practice as primary care physicians for the better: POEMs = Patient Oriented Evidence that Matters.

Share Episode 6: Probiotics reduce likelihood of frequent UTIs

Sign up to save your podcasts

Episode 6: Probiotics reduce likelihood of frequent UTIs

Episode 6: Probiotics reduce likelihood of frequent UTIs